A Population-based Study of the Effectiveness of Stereotactic Ablative Radiotherapy Versus Conventional Fractionated Radiotherapy for Clinical Stage I Non-small Cell Lung Cancer Patients

scientific article published on 07 December 2017

A Population-based Study of the Effectiveness of Stereotactic Ablative Radiotherapy Versus Conventional Fractionated Radiotherapy for Clinical Stage I Non-small Cell Lung Cancer Patients is …
instance of (P31):
scholarly articleQ13442814

External links are
P356DOI10.1515/RAON-2017-0058
P932PMC publication ID6043889
P698PubMed publication ID30018522

P2093author name stringJi-An Liang
Su-Tso Yang
Te-Chun Hsia
Hsin-Yuan Fang
Chih-Yen Tu
Chun-Ru Chien
Chia-Chin Li
P2860cites workStereotactic body radiation therapy versus conventional radiation therapy in patients with early stage non-small cell lung cancer: an updated retrospective study on local failure and survival rates.Q50787344
Increasing radiation therapy dose is associated with improved survival in patients undergoing stereotactic body radiation therapy for stage I non-small-cell lung cancer.Q51061126
The Strengthening the Reporting of Observational Studies in Epidemiology (STROBE) Statement: guidelines for reporting observational studies.Q51811363
SPACE - A randomized study of SBRT vs conventional fractionated radiotherapy in medically inoperable stage I NSCLC.Q53781022
Adjusted survival curves with inverse probability weightsQ80121057
Stereotactic radiotherapy reduces treatment cost while improving overall survival and local control over standard fractionated radiation therapy for medically inoperable non-small-cell lung cancerQ84968231
A critical review of recent developments in radiotherapy for non-small cell lung cancerQ28079625
Stereotactic ablative radiotherapy versus lobectomy for operable stage I non-small-cell lung cancer: a pooled analysis of two randomised trialsQ30656342
Stereotactic body radiation therapy for inoperable early stage lung cancerQ34010065
Methods for constructing and assessing propensity scoresQ34417811
The use of propensity score methods with survival or time-to-event outcomes: reporting measures of effect similar to those used in randomized experimentsQ34842079
Cost and effectiveness of image-guided radiotherapy for non-operated localized lung cancer: a population-based propensity score-matched analysisQ36138377
Moving towards best practice when using inverse probability of treatment weighting (IPTW) using the propensity score to estimate causal treatment effects in observational studiesQ36225803
Geographic variation in the use of adjuvant therapy among elderly patients with resected non-small cell lung cancerQ36774403
Comparative effectiveness of 5 treatment strategies for early-stage non-small cell lung cancer in the elderlyQ37180820
Effect of image-guided hypofractionated stereotactic radiotherapy on peripheral non-small-cell lung cancerQ37194294
Efficacy of stereotactic body radiotherapy for hepatocellular carcinoma with portal vein tumor thrombosis/inferior vena cava tumor thrombosis: evaluation by comparison with conventional three-dimensional conformal radiotherapyQ37301050
Definition of stereotactic body radiotherapy: principles and practice for the treatment of stage I non-small cell lung cancerQ37468265
Comparison of the effectiveness of radiotherapy with photons, protons and carbon-ions for non-small cell lung cancer: a meta-analysisQ37592621
Population-based differences in treatment outcome following anticancer drug therapies.Q37686610
Stereotactic ablative radiotherapy for centrally located early stage non-small-cell lung cancer: what we have learnedQ38290655
Quality assessment and improvement of nationwide cancer registration system in Taiwan: a review.Q38324572
The role of PET-CT in radiotherapy planning of solid tumoursQ38391624
Outcomes in stage I non-small cell lung cancer following the introduction of stereotactic body radiotherapy in Alberta - A population-based studyQ38582913
Sensitivity Analysis in Observational Research: Introducing the E-ValueQ38686086
Stereotactic body radiotherapy for early stage lung cancer: History and updated roleQ38704840
A systematic review of outcomes following stereotactic ablative radiotherapy in the treatment of early-stage primary lung cancerQ38790915
Radiotherapy in the multidisciplinary treatment of liver cancer: a survey on behalf of the Italian Association of Radiation Oncology.Q38973851
Variance estimation when using inverse probability of treatment weighting (IPTW) with survival analysisQ39466085
Survival and quality of life after stereotactic or 3D-conformal radiotherapy for inoperable early-stage lung cancerQ45082070
Cost-effectiveness analysis comparing conventional versus stereotactic body radiotherapy for surgically ineligible stage I non-small-cell lung cancerQ47603621
Radiation therapy after breast-conserving surgery: does hospital surgical volume matter? A population-based study in TaiwanQ50124547
P275copyright licenseCreative Commons Attribution-NonCommercial-NoDerivs 3.0 UnportedQ19125045
P6216copyright statuscopyrightedQ50423863
P433issue2
P921main subjectnon-small-cell lung carcinomaQ3658562
P304page(s)181-188
P577publication date2017-12-07
P1433published inRadiology and OncologyQ26842803
P1476titleA Population-based Study of the Effectiveness of Stereotactic Ablative Radiotherapy Versus Conventional Fractionated Radiotherapy for Clinical Stage I Non-small Cell Lung Cancer Patients
P478volume52